The company told Reuters that 49% of Black volunteers did not meet the trial's amyloid threshold requirements compared to 22% for whites and 55% for Hispanics.
"Is it because MCI (mild cognitive impairment) or early dementia type-symptoms in Blacks are caused by other reasons more so than Alzheimer's?"
In 96 dementia trials from 2000-2017, diverse populations only made up around 11% of enrollment, according to a 2018 study.
Among Black people who died of Alzheimer's, their dementia was more likely to result from multiple causes, such as vascular disease.
"Is it that it's not Alzheimer's disease?
Persons:
Barrington, Vickie Riley, Charlie, Harriet Shaffer, Barrington Riley, –, Eli Lilly, Lilly, Crystal Glover, Eisai, Ivan Cheung, Cheung, Shobha, Biogen, Mark Mintun, Alzheimer's, Dr Lisa Barnes, Barnes, Joshua Grill, we're, Reisa Sperling, Brigham, Julie Steenhuysen, Caroline Humer, Suzanne Goldenberg, Daniel Flynn
Organizations:
Emory University Brain Health, Americans, Reuters, Prospective Black, Rush, Disease Research, and Drug Administration, FDA, Black, MCI, National Institutes of Health, Rush Center, University of California, Women's Hospital, Thomson
Locations:
Atlanta , Georgia, U.S, Chicago, Tokyo, Irvine, United States